Ramadevi Bhimavarapu, Ramesetti RamaDevi, Srinath Nissankararao, Chaitanya Devarapalli, Sowjanya Paparaju
Ramadevi Bhimavarapu, Ramesetti RamaDevi*, Srinath Nissankararao, Chaitanya Devarapalli ,Sowjanya Paparaju
Sri Siddhartha Pharmacy College, Nuzvid
Volume - 6,
Issue - 8,
Year - 2013
Microsponge delivery systems (MDS) that can precisely control the release rates or target drugs to a specific body site have an enormous impact on the health care system. The microsponge drug delivery technology is widely applicable to the dermatological drug delivery products. The microsponge drug delivery system has properties like improved stability and enhanced flexibility in formulation. MDS is originally developed for topical delivery of drugs like antiacne, anti-inflammatory, anti-fungal, antidandruffs, antipruritics, rubefacients etc. MDS holds a promising future in various pharmaceutical applications in the coming years by virtue of their unique properties like small size, efficient carrier characteristics enhanced product performance and elegancy, extended release, reduced irritation, improved thermal, physical, and chemical stability so flexible to develop novel product forms. But MDS also expands its application in oral drug delivery, bone and tissue engineering, in detecting the diseases and in RNAi silencing. New classes of pharmaceuticals, biopharmaceuticals (peptides, proteins and DNA-based therapeutics) are fueling the rapid evolution of drug delivery technology. Thus MDS is a very emerging field which is needed to be explored.
Cite this article:
Ramadevi Bhimavarapu, Ramesetti RamaDevi, Srinath Nissankararao, Chaitanya Devarapalli, Sowjanya Paparaju. Research J. Pharm. and Tech. 6(8): August 2013; Page 842-848.
Ramadevi Bhimavarapu, Ramesetti RamaDevi, Srinath Nissankararao, Chaitanya Devarapalli, Sowjanya Paparaju. Research J. Pharm. and Tech. 6(8): August 2013; Page 842-848. Available on: https://rjptonline.org/AbstractView.aspx?PID=2013-6-8-15